Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 103

    1.

    Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial.

    Taylor GP, Goon P, Furukawa Y, Green H, Barfield A, Mosley A, Nose H, Babiker A, Rudge P, Usuku K, Osame M, Bangham CR, Weber JN.

    Retrovirology. 2006 Sep 19;3:63.

    PMID:
    16984654
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    The effect of antiretroviral therapy on HTLV infection.

    Machuca A, Rodés B, Soriano V.

    Virus Res. 2001 Oct 30;78(1-2):93-100.

    PMID:
    11520583
    [PubMed - indexed for MEDLINE]
    3.

    Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru.

    Best I, Adaui V, Verdonck K, González E, Tipismana M, Clark D, Gotuzzo E, Vanham G.

    Clin Exp Immunol. 2006 Nov;146(2):226-33.

    PMID:
    17034574
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    In vivo fluctuation of HTLV-I and HTLV-II proviral load in patients receiving antiretroviral drugs.

    Machuca A, Soriano V.

    J Acquir Immune Defic Syndr. 2000 Jun 1;24(2):189-93.

    PMID:
    10935697
    [PubMed - indexed for MEDLINE]
    5.

    Phase II study of vicriviroc versus efavirenz (both with zidovudine/lamivudine) in treatment-naive subjects with HIV-1 infection.

    Landovitz RJ, Angel JB, Hoffmann C, Horst H, Opravil M, Long J, Greaves W, Fätkenheuer G.

    J Infect Dis. 2008 Oct 15;198(8):1113-22.

    PMID:
    18783318
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Pilot study of once-daily simplification therapy with abacavir/lamivudine/zidovudine and efavirenz for treatment of HIV-1 infection.

    Ruane P, Lang J, DeJesus E, Berger DS, Dretler R, Rodriguez A, Ward DJ, Lim ML, Liao Q, Reddy S, Clair MS, Vila T, Shaefer MS.

    HIV Clin Trials. 2006 Sep-Oct;7(5):229-36.

    PMID:
    17162316
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT).

    Arasteh K, Weitner L, Fenske S, Kuhlmann B, Freiwald M, Ebrahimi R, Gallo L, Ranneberg R, Mertenskoetter T.

    Eur J Med Res. 2009 May 14;14(5):195-9.

    PMID:
    19541575
    [PubMed - indexed for MEDLINE]
    8.

    Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.

    Nishiura Y, Nakamura T, Fukushima N, Nakamura H, Ida H, Aramaki T, Eguchi K.

    Antivir Ther. 2009;14(4):533-42.

    PMID:
    19578238
    [PubMed - indexed for MEDLINE]
    9.

    Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903.

    Berenguer J, González J, Ribera E, Domingo P, Santos J, Miralles P, Angels Ribas M, Asensi V, Gimeno JL, Pérez-Molina JA, Terrón JA, Santamaría JM, Pedrol E; GESIDA 3903 Team.

    Clin Infect Dis. 2008 Oct 15;47(8):1083-92. Erratum in: Clin Infect Dis. 2008 Dec 15;47(12):1611.

    PMID:
    18781872
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.

    Casseb J, de Oliveira AC, Vergara MP, Montanheiro P, Bonasser F, Meilman Ferreira C, Smid J, Duarte AJ.

    J Med Virol. 2008 Mar;80(3):392-8.

    PMID:
    18205234
    [PubMed - indexed for MEDLINE]
    11.

    Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patients.

    Rey D, Krebs M, Partisani M, Hess G, Cheneau C, Priester M, Bernard-Henry C, de Mautort E, Lang JM.

    J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):530-4.

    PMID:
    17057610
    [PubMed - indexed for MEDLINE]
    12.

    A combination drug of abacavir-lamivudine-zidovudine (Trizivir) for treating HIV infection and AIDS.

    Shey M, Kongnyuy EJ, Shang J, Wiysonge CS.

    Cochrane Database Syst Rev. 2009 Jul 8;(3):CD005481. Review.

    PMID:
    19588374
    [PubMed - indexed for MEDLINE]
    13.

    Quadruple nucleos(t)ide reverse transcriptase inhibitors-only regimen of tenofovir plus zidovudine/lamivudine/abacavir in heavily pre-treated HIV-1 infected patients: salvage therapy or backbone only?

    Stephan C, Dauer B, Khaykin P, Stuermer M, Gute P, Klauke S, Staszewski S.

    Curr HIV Res. 2009 May;7(3):320-6.

    PMID:
    19442129
    [PubMed - indexed for MEDLINE]
    14.

    The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis.

    Michaëlsson J, Barbosa HM, Jordan KA, Chapman JM, Brunialti MK, Neto WK, Nukui Y, Sabino EC, Chieia MA, Oliveira AS, Nixon DF, Kallas EG.

    BMC Immunol. 2008 Jul 29;9:41.

    PMID:
    18664281
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease.

    Oh U, Yamano Y, Mora CA, Ohayon J, Bagnato F, Butman JA, Dambrosia J, Leist TP, McFarland H, Jacobson S.

    Ann Neurol. 2005 Apr;57(4):526-34.

    PMID:
    15786444
    [PubMed - indexed for MEDLINE]
    17.

    Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.

    Hoen B, Cooper DA, Lampe FC, Perrin L, Clumeck N, Phillips AN, Goh LE, Lindback S, Sereni D, Gazzard B, Montaner J, Stellbrink HJ, Lazzarin A, Ponscarme D, Staszewski S, Mathiesen L, Smith D, Finlayson R, Weber R, Wegmann L, Janossy G, Kinloch-de Loes S; QUEST Study Group.

    Clin Infect Dis. 2007 Aug 1;45(3):381-90. Epub 2007 Jun 26.

    PMID:
    17599319
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

    Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K, Matsuoka M, Ohara Y.

    Retrovirology. 2009 Feb 19;6:19.

    PMID:
    19228429
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/abacavir as a first-line regimen.

    Stürmer M, Dauer B, Moesch M, Haberl A, Mueller A, Locher L, Knecht G, Hanke N, Doerr HW, Staszewski S.

    Antivir Ther. 2007;12(1):25-30.

    PMID:
    17503744
    [PubMed - indexed for MEDLINE]
    20.

    Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients.

    Masquelier B, Neau D, Boucher S, Lavignolle-Aurillac V, Schrive MH, Recordon-Pinson P, Ragnaud JM, Fleury H.

    Antivir Ther. 2006;11(6):827-30.

    PMID:
    17310827
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk